{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T10:13:31Z","timestamp":1783678411359,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"DOI":"10.1007\/s00223-026-01555-1","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T09:18:59Z","timestamp":1783675139000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Insight into Natural History and Phenotype in Untreated Adults with X-Linked Hypophosphatemia"],"prefix":"10.1007","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8465-5087","authenticated-orcid":false,"given":"Giampiero I.","family":"Baroncelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2558-9547","authenticated-orcid":false,"given":"Filomena","family":"Cetani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4193-4128","authenticated-orcid":false,"given":"Benedetta","family":"Toschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1053-0512","authenticated-orcid":false,"given":"Alessandra","family":"Bulleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9439-6135","authenticated-orcid":false,"given":"Alessandro","family":"Isola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4575-9761","authenticated-orcid":false,"given":"Maria Rita","family":"Giuca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5494-8591","authenticated-orcid":false,"given":"Elisabetta","family":"Carli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2839-370X","authenticated-orcid":false,"given":"Maria Rita","family":"Sessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8322-6205","authenticated-orcid":false,"given":"Caterina","family":"Pelosini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0173-325X","authenticated-orcid":false,"given":"Angela","family":"Michelucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5209-9733","authenticated-orcid":false,"given":"Pasquale","family":"Comberiati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"1555_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.688309","volume":"12","author":"GI Baroncelli","year":"2021","unstructured":"Baroncelli GI, Mora S (2021) X-linked hypophosphatemic rickets: multisystemic disorder in children requiring multidisciplinary management. Front Endocrinol 12:688309. https:\/\/doi.org\/10.3389\/fendo.2021.688309","journal-title":"Front Endocrinol"},{"key":"1555_CR2","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1007\/s00467-024-06395-5","volume":"39","author":"R Wilson","year":"2024","unstructured":"Wilson R, Mukherjee-Roy N, Gattineni J (2024) The role of fibroblast growth factor 23 in regulation of phosphate balance. Pediatr Nephrol 39:3439\u20133451. https:\/\/doi.org\/10.1007\/s00467-024-06395-5","journal-title":"Pediatr Nephrol"},{"key":"1555_CR3","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1172\/JCI32702","volume":"118","author":"B Yuan","year":"2008","unstructured":"Yuan B, Takaiwa M, Clemens TL, Feng JQ, Kumar R, Rowe PS, Xie Y, Drezner MK (2008) Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia. J Clin Invest 118:722\u2013734. https:\/\/doi.org\/10.1172\/JCI32702","journal-title":"J Clin Invest"},{"key":"1555_CR4","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/S0140-6736(24)01305-9","volume":"404","author":"P Kamenick\u00fd","year":"2024","unstructured":"Kamenick\u00fd P, Briot K, Munns CF, Linglart A (2024) X-linked hypophosphataemia. Lancet 404:887\u2013901. https:\/\/doi.org\/10.1016\/S0140-6736(24)01305-9","journal-title":"Lancet"},{"key":"1555_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.archoralbio.2005.05.005","volume":"51","author":"T Ogawa","year":"2006","unstructured":"Ogawa T, Onishi T, Hayashibara T, Sakashita S, Okawa R, Ooshima T (2006) Dentinal defects in Hyp mice not caused by hypophosphatemia alone. Arch Oral Biol 51:58\u201363. https:\/\/doi.org\/10.1016\/j.archoralbio.2005.05.005","journal-title":"Arch Oral Biol"},{"key":"1555_CR6","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1002\/jbmr.3843","volume":"34","author":"KL Insogna","year":"2019","unstructured":"Insogna KL, Rauch F, Kamenick\u00fd P, Ito N, Kubota T, Nakamura A, Zhang L, Mealiffe M, San Martin J, Portale AA (2019) Burosumab improved histomorphometric measures of osteomalacia in adults with X-linked hypophosphatemia: a phase 3, single-arm, international trial. J Bone Miner Res 34:2183\u20132191. https:\/\/doi.org\/10.1002\/jbmr.3843","journal-title":"J Bone Miner Res"},{"key":"1555_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-010-9373-0","volume":"87","author":"SS Beck-Nielsen","year":"2010","unstructured":"Beck-Nielsen SS, Brusgaard K, Rasmussen LM, Brixen K, Brock-Jacobsen B, Poulsen MR, Vestergaard P, Ralston SH, Albagha OME, Poulsen S, Haubek D, Gj\u00f8rup H, Hintze H, Andersen MG, Heickendorff L, Hjelmborg J, Gram J (2010) Phenotype presentation of hypophosphatemic rickets in adults. Calcif Tissue Int 87:108119. https:\/\/doi.org\/10.1007\/s00223-010-9373-0","journal-title":"Calcif Tissue Int"},{"key":"1555_CR8","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s10545-018-0147-6","volume":"41","author":"D Chesher","year":"2018","unstructured":"Chesher D, Oddy M, Darbar U, Sayal P, Casey A, Ryan A, Sechi A, Simister C, Waters A, Wedatilake Y, Lachmann RH, Murphy E (2018) Outcome of adult patients with X-linked hypophosphatemia caused by PHEX gene mutations. J Inherit Metab Dis 41:865\u2013876. https:\/\/doi.org\/10.1007\/s10545-018-0147-6","journal-title":"J Inherit Metab Dis"},{"key":"1555_CR9","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1210\/js.2018-00365","volume":"3","author":"A Skrinar","year":"2019","unstructured":"Skrinar A, Dvorak-Ewell M, Evins A, Macica C, Linglart A, Imel EA, Theodore-Oklota C, San Martin J (2019) The lifelong impact of X-linked hypophosphatemia: results from a burden of disease survey. J Endocr Soc 3:1321\u20131334. https:\/\/doi.org\/10.1210\/js.2018-00365","journal-title":"J Endocr Soc"},{"key":"1555_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00198-020-05548-0","volume":"32","author":"L Seefried","year":"2020","unstructured":"Seefried L, Smyth M, Keen R, Harvengt P (2020) Burden of disease associated with X-linked hypophosphataemia in adults: a systematic literature review. Osteoporos Int 32:7\u201322. https:\/\/doi.org\/10.1007\/s00198-020-05548-0","journal-title":"Osteoporos Int"},{"key":"1555_CR11","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s00198-021-05997-1","volume":"32","author":"S Giannini","year":"2021","unstructured":"Giannini S, Bianchi ML, Rendina D, Massoletti P, Lazzerrini D, Brandi ML (2021) Burden of disease and clinical targets in adult patients with X-linked hypophosphatemia. A comprehensive review. Osteoporos Int 32:1937\u20131949. https:\/\/doi.org\/10.1007\/s00198-021-05997-1","journal-title":"Osteoporos Int"},{"key":"1555_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s11657-025-01544-1","volume":"20","author":"KM Dahir","year":"2025","unstructured":"Dahir KM, Li Z, Heerssen HM, Noman A, Kim J, Zhao Y, Imel EA (2025) Real-world characteristics and disease history of patients with X-linked hypophosphatemia before treatment with burosumab. Arch Osteoporos 20:64. https:\/\/doi.org\/10.1007\/s11657-025-01544-1","journal-title":"Arch Osteoporos"},{"key":"1555_CR13","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1007\/s40618-025-02611-7","volume":"48","author":"GI Baroncelli","year":"2025","unstructured":"Baroncelli GI, Barale M, Brandi ML, Camozzi V, Carrara S, Caruso Nicoletti M, Castellano E, Cetani F, Comberiati P, Di Iorgi N, Eller-Vainicher C, Emma F et al (2025) Experts\u2019 consensus on the management and treatment of individuals with X-linked hypophosphatemia across lifespan. J Endocrinol Invest 48:2199\u20132228. https:\/\/doi.org\/10.1007\/s40618-025-02611-7","journal-title":"J Endocrinol Invest"},{"key":"1555_CR14","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1530\/EJE-15-0661","volume":"174","author":"H Che","year":"2016","unstructured":"Che H, Roux C, Etcheto A, Rothenbuhler A, Kamenicky P, Linglart A, Briot K (2016) Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms. Eur J Endocrinol 174:325\u2013333. https:\/\/doi.org\/10.1530\/EJE-15-0661","journal-title":"Eur J Endocrinol"},{"key":"1555_CR15","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvab070","volume":"5","author":"M Cheung","year":"2021","unstructured":"Cheung M, Rylands AJ, Williams A, Bailey K, Bubbear J (2021) Patient-reported complications, symptoms, and experiences of living with X-linked hypophosphatemia across the life-course. J Endocr Soc 5:bvab070. https:\/\/doi.org\/10.1210\/jendso\/bvab070","journal-title":"J Endocr Soc"},{"key":"1555_CR16","doi-asserted-by":"publisher","first-page":"e1249","DOI":"10.1210\/clinem\/dgab739","volume":"107","author":"MK Javaid","year":"2022","unstructured":"Javaid MK, Ward L, Pinedo-Villaneuva R, Rylands AJ, Williams A, Insogna K, Imel EA (2022) Musculo-skeletal features in adults with X-linked hypophosphatemia: an analysis of clinical trial and survey data. J Clin Endocrinol Metab 107:e1249\u2013e1262. https:\/\/doi.org\/10.1210\/clinem\/dgab739","journal-title":"J Clin Endocrinol Metab"},{"key":"1555_CR17","doi-asserted-by":"publisher","first-page":"e3886","DOI":"10.1210\/clinem\/dgaf104","volume":"110","author":"M Diaz-delCastillo","year":"2025","unstructured":"Diaz-delCastillo M, Espersen RR, Beck-Nielsen SS, Rejnmark L, Heegaard AM (2025) Pain, quality of life and mental health in adults with X-linked hypophosphatemia: a cross-sectional study. J Clin Endocrinol Metab 110:e3886\u2013e3896. https:\/\/doi.org\/10.1210\/clinem\/dgaf104","journal-title":"J Clin Endocrinol Metab"},{"key":"1555_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-025-01433-2","volume":"116","author":"J Bubbear","year":"2025","unstructured":"Bubbear J, Lachmann R, Murphy E, Krishna G, Clunie GPR, Walsh J, Schini M, Salam S, Roy M, Finezilber Y, Mathieson L, Hayes V et al (2025) Real\u2010world effectiveness of burosumab in adults with X\u2010linked hypophosphataemia (XLH) in the UK. Calcif Tissue Int 116:122. https:\/\/doi.org\/10.1007\/s00223-025-01433-2","journal-title":"Calcif Tissue Int"},{"key":"1555_CR19","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1210\/jc.2003-030036","volume":"88","author":"O Makitie","year":"2003","unstructured":"Makitie O, Doria A, Kooh SW, Cole WG, Daneman A, Sochett E (2003) Early treatment improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 88:3591\u20133597. https:\/\/doi.org\/10.1210\/jc.2003-030036","journal-title":"J Clin Endocrinol Metab"},{"key":"1555_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0221-8747(82)90035-2","volume":"4","author":"PJ Marie","year":"1982","unstructured":"Marie PJ, Glorieux FH (1982) Bone histomorphometry in asyntomatic adults with hereditary hypophosphatemic vitamin D-resistant osteomalacia. Metab Bone Dis Relat Res 4:249\u2013253. https:\/\/doi.org\/10.1016\/0221-8747(82)90035-2","journal-title":"Metab Bone Dis Relat Res"},{"key":"1555_CR21","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/jbmr.340","volume":"26","author":"TO Carpenter","year":"2011","unstructured":"Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL (2011) A clinician\u2019s guide to X-linked hypophosphatemia. J Bone Miner Res 26:1381\u20131388. https:\/\/doi.org\/10.1002\/jbmr.340","journal-title":"J Bone Miner Res"},{"key":"1555_CR22","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1210\/JC.2015-2199","volume":"100","author":"J Connor","year":"2015","unstructured":"Connor J, Olear EA, Insogna KL, Katz L, Baker S, Kaur R, Simpson CA, Sterpka J, Dubrov R, Zhang JH, Carpenter TO (2015) Conventional therapy in adults with X-linked hypophosphatemia: effects on enthesopathy and dental disease. J Clin Endocrinol Metab 100:3625\u20133632. https:\/\/doi.org\/10.1210\/JC.2015-2199","journal-title":"J Clin Endocrinol Metab"},{"key":"1555_CR23","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/s41581-024-00926-x","volume":"21","author":"D Haffner","year":"2025","unstructured":"Haffner D, Emma F, Seefried L, H\u00f6gler W, Javaid KM, Bockenhauer D, Bacchetta J, Eastwood D, Duplan MB, Schnabel D, Wicart P, Ariceta G et al (2025) Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nat Rev Nephrol 21:330\u2013354. https:\/\/doi.org\/10.1038\/s41581-024-00926-x","journal-title":"Nat Rev Nephrol"},{"key":"1555_CR24","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.bone.2019.06.025","volume":"127","author":"S DeLacey","year":"2019","unstructured":"DeLacey S, Liu Z, Broyles A, El-Azab SA, Guandique CF, James BC, Imel EA (2019) Hyperparathyroidism and parathyroidectomy in X-linked hypophosphatemia patients. Bone 127:386\u2013392. https:\/\/doi.org\/10.1016\/j.bone.2019.06.025","journal-title":"Bone"},{"key":"1555_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/adc.73.1.17","volume":"73","author":"JV Freeman","year":"1995","unstructured":"Freeman JV, Cole TJ, Chinn S, Jones PRM, White EM, Preece MA (1995) Cross sectional stature and weight reference curves for the UK, 1990. Arch Dis Child 73:17\u201324. https:\/\/doi.org\/10.1136\/adc.73.1.17","journal-title":"Arch Dis Child"},{"key":"1555_CR26","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1136\/adc.2004.050799","volume":"90","author":"AM Fredriks","year":"2005","unstructured":"Fredriks AM, van Buuren S, van Heel WJM, Dijkman-Neerincx RHM, Verloove-Vanhorick SP, Wit JM (2005) Nationwide age references for sitting height, leg length, and sitting height\/height ratio, and their diagnostic value for disproportionate growth disorders. Arch Dis Child 90:807\u2013812. https:\/\/doi.org\/10.1136\/adc.2004.050799","journal-title":"Arch Dis Child"},{"key":"1555_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000184216","volume":"44","author":"H Stark","year":"1986","unstructured":"Stark H, Eisenstein B, Tieder M, Rachmel A, Alpert G (1986) Direct measurement of TP\/GFR: a simple and reliable parameter of renal phosphate handling. Nephron 44:125\u2013128. https:\/\/doi.org\/10.1159\/000184216","journal-title":"Nephron"},{"key":"1555_CR28","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s40618-023-02202-4","volume":"47","author":"GI Baroncelli","year":"2024","unstructured":"Baroncelli GI, Sessa MR, Pelosini C, Bertelloni S, Michelucci A, Toschi B, Piaggi P, Peroni D, Comberiati P (2024) Intact FGF23 concentration in healthy infants, children, and adolescents, and diagnostic usefulness in patients with X-linked hypophosphatemic rickets. J Endocrinol Invest 47:873\u2013882. https:\/\/doi.org\/10.1007\/s40618-023-02202-4","journal-title":"J Endocrinol Invest"},{"key":"1555_CR29","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.jval.2018.01.013","volume":"21","author":"C Theodore-Oklota","year":"2018","unstructured":"Theodore-Oklota C, Bonner N, Spencer H, Arbuckle R, Chen CY, Skrinar A (2018) Qualitative research to explore the patient experience of X-linked hypophosphatemia and evaluate the suitability of the BPI-SF and WOMAC as clinical trial end points. Value Health 21:973\u2013983. https:\/\/doi.org\/10.1016\/j.jval.2018.01.013","journal-title":"Value Health"},{"key":"1555_CR30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.gerinurse.2023.04.011","volume":"52","author":"ACL Ferreira","year":"2023","unstructured":"Ferreira ACL, Pereira DS, da Silva SLA, Carvalho GA, Pereira LSM (2023) Validity and reliability of the short form brief pain inventory in older adults with nociceptive, neuropathic and nociplastic pain. Geriatr Nurs 52:16\u201323. https:\/\/doi.org\/10.1016\/j.gerinurse.2023.04.011","journal-title":"Geriatr Nurs"},{"key":"1555_CR31","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1037\/1040-3590.7.4.524","volume":"7","author":"MJL Sullivan","year":"1995","unstructured":"Sullivan MJL, Bishop SR, Pivik J (1995) The pain catastrophizing scale: development and validation. Psychol Assess 7:524\u2013532. https:\/\/doi.org\/10.1037\/1040-3590.7.4.524","journal-title":"Psychol Assess"},{"key":"1555_CR32","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16:606\u2013613. https:\/\/doi.org\/10.1046\/j.1525-1497.2001.016009606.x","journal-title":"J Gen Intern Med"},{"key":"1555_CR33","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1067\/mpd.2003.119","volume":"142","author":"C Chaussain-Miller","year":"2003","unstructured":"Chaussain-Miller C, Sinding C, Wolikow M, Lasfargues J-J, Godeau G, Garab\u00e9dian M (2003) Dental abnormalities in patients with familial hypophosphatemic vitamin D-resistant rickets: prevention by early treatment with 1-hydroxyvitamin D. J Pediatr 142:324\u2013331. https:\/\/doi.org\/10.1067\/mpd.2003.119","journal-title":"J Pediatr"},{"key":"1555_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM198507043130101","volume":"313","author":"RP Polisson","year":"1985","unstructured":"Polisson RP, Martinez S, Khoury M, Harrell RM, Lyles KW, Friedman N, Harrelson JM, Reisner E, Drezner MK (1985) Calcification of entheses associated with X-linked hypophosphatemic osteomalacia. N Engl J Med 313:1\u20136. https:\/\/doi.org\/10.1056\/NEJM198507043130101","journal-title":"N Engl J Med"},{"key":"1555_CR35","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1148\/radiology.171.2.2539609","volume":"171","author":"DC Hardy","year":"1989","unstructured":"Hardy DC, Murphy WA, Siegel BA, Reid IR, Whyte MP (1989) X-linked hypophosphatemia in adults: prevalence of skeletal radiographic and scintigraphic features. Radiology 171:403\u2013414. https:\/\/doi.org\/10.1148\/radiology.171.2.2539609","journal-title":"Radiology"},{"key":"1555_CR36","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/00005792-198911000-00002","volume":"68","author":"IR Reid","year":"1989","unstructured":"Reid IR, Hardy DC, Murphy WA, Teitelbaum SL, Bergfeld MA, Whyte MP (1989) X-linked hypophosphatemia: a clinical, biochemical, and histopathologic assessment of morbidity in adults. Medicine 68:336\u2013352 (PMID:2811660)","journal-title":"Medicine"},{"key":"1555_CR37","doi-asserted-by":"publisher","first-page":"e1798","DOI":"10.1210\/clinem\/dgaa064","volume":"105","author":"A Steele","year":"2020","unstructured":"Steele A, Gonzalez R, Garbalosa JC, Steigbigel K, Grgurich T, Parisi EJ, Feinn RS, Tommasini SM, Macica CM (2020) Osteoarthritis, osteophytes, and enthesophytes affect biomechanical function in adults with X-linked hypophosphatemia. J Clin Endocrinol Metab 105:e1798\u2013e1814. https:\/\/doi.org\/10.1210\/clinem\/dgaa064","journal-title":"J Clin Endocrinol Metab"},{"key":"1555_CR38","doi-asserted-by":"publisher","DOI":"10.1093\/jbmrpl\/ziaf113","volume":"9","author":"L Bachfischer","year":"2025","unstructured":"Bachfischer L, Behanova M, Rath E, Meng S, Mittelbach A, Haschka J, Dechat T, Raimann A, Mindler G, Uyanik G, Zwerina J, Kocijan R (2025) Prevalence of enthesopathies in X-linked hypophosphatemia: an explorative ultrasound study. JBMR Plus 9:ziaf113. https:\/\/doi.org\/10.1093\/jbmrpl\/ziaf113","journal-title":"JBMR Plus"},{"key":"1555_CR39","doi-asserted-by":"publisher","first-page":"e1524","DOI":"10.1210\/clinem\/dgad383","volume":"108","author":"J Herrou","year":"2023","unstructured":"Herrou J, Fechtenbaum J, Rothenbuhler A, Kamenick\u00fd P, Roux C, Linglart A, Briot K (2023) Development of spinal enthesopathies in adults with X-linked hypophosphatemia. J Clin Endocrinol Metab 108:e1524\u2013e1531. https:\/\/doi.org\/10.1210\/clinem\/dgad383","journal-title":"J Clin Endocrinol Metab"},{"key":"1555_CR40","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1210\/clinem\/dgac543","volume":"107","author":"MN M\u00e9aux","year":"2022","unstructured":"M\u00e9aux MN, Alioli C, Linglart A, Lemoine S, Vignot E, Bertholet-Thomas A, Peyruchaud O, Flammier S, Machuca-Gayet I, Bacchetta J (2022) X-linked hypophosphatemia, not only a skeletal disease but also a chronic inflammatory state. J Clin Endocrinol Metab 107:3275\u20133286. https:\/\/doi.org\/10.1210\/clinem\/dgac543","journal-title":"J Clin Endocrinol Metab"},{"key":"1555_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10728","volume":"7","author":"CF Munns","year":"2023","unstructured":"Munns CF, Maguire EP, Williams A, Wood S, Biggin A (2023) Craniosynostosis in patients with X-linked hypophosphatemia: a review. JBMR Plus 7:e10728. https:\/\/doi.org\/10.1002\/jbm4.10728","journal-title":"JBMR Plus"},{"key":"1555_CR42","doi-asserted-by":"publisher","first-page":"e488","DOI":"10.1210\/clinem\/dgad608","volume":"109","author":"A Bouzemane","year":"2024","unstructured":"Bouzemane A, Vignot E, Derain Dubourg L, De Mul A, Molin A, Chapurlat R, Fontanges E, Delsart D, Akbari A, Huang SHS, McIntyre CW, Bacchetta J, Lemoine S (2024) Reassuring data on the cardiovascular risk in adults with X-linked hypophosphatemia receiving conventional therapy. J Clin Endocrinol Metab 109:e488\u2013e494. https:\/\/doi.org\/10.1210\/clinem\/dgad608","journal-title":"J Clin Endocrinol Metab"},{"key":"1555_CR43","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00223-017-0363-3","volume":"102","author":"VV Shanbhogue","year":"2018","unstructured":"Shanbhogue VV, Hansen S, Jorgensen NR, Beck-Nielsen SS (2018) Impact of conventional medical therapy on bone mineral density and bone turnover in adult patients with X-linked hypophosphatemia: a 6-year prospective cohort study. Calcif Tissue Int 102:321\u2013328. https:\/\/doi.org\/10.1007\/s00223-017-0363-3","journal-title":"Calcif Tissue Int"},{"key":"1555_CR44","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00774-018-0957-5","volume":"37","author":"MJ McKenna","year":"2019","unstructured":"McKenna MJ, Martin-Grace J, Crowley R, Twomey PJ, Kilbane MT (2019) Congenital hypophosphataemia in adults: determinants of bone turnover markers and amelioration of renal phosphate wasting following total parathyroidectomy. J Bone Miner Metab 37:685\u2013693. https:\/\/doi.org\/10.1007\/s00774-018-0957-5","journal-title":"J Bone Miner Metab"},{"key":"1555_CR45","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00223-019-00526-z","volume":"104","author":"S Hansen","year":"2019","unstructured":"Hansen S, Shanbhogue VV, Jorgensen NR, Beck-Nielsen SS (2019) Elevated bone remodeling markers of CTX and P1NP in addition to sclerostin in patients with X-linked hypophosphatemia: a cross-sectional controlled study. Calcif Tissue Int 104:591\u2013598. https:\/\/doi.org\/10.1007\/s00223-019-00526-z","journal-title":"Calcif Tissue Int"},{"key":"1555_CR46","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s12020-011-9512-z","volume":"40","author":"Y Nagata","year":"2011","unstructured":"Nagata Y, Imanishi Y, Ishii A, Kurajoh M, Motoyama K, Morioka T, Naka H, Mori K, Miki T, Emoto M, Inaba M (2011) Evaluation of bone markers in hypophosphatemic rickets\/osteomalacia. Endocrine 40:315\u2013317. https:\/\/doi.org\/10.1007\/s12020-011-9512-z","journal-title":"Endocrine"},{"key":"1555_CR47","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s00774-004-0594-z","volume":"23","author":"I Ros","year":"2005","unstructured":"Ros I, Alvarez L, Guanabens N, Peris P, Monegal A, Vazquez I, Cerda D, Ballesta AM, Munoz-Gomez J (2005) Hypophosphatemic osteomalacia: a report of five cases and evaluation of bone markers. J Bone Miner Metab 23:266\u2013269. https:\/\/doi.org\/10.1007\/s00774-004-0594-z","journal-title":"J Bone Miner Metab"},{"key":"1555_CR48","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1210\/jcem.81.11.8923863","volume":"81","author":"MP Whyte","year":"1996","unstructured":"Whyte MP, Schranck FW, Armamento-Villareal R (1996) X-linked hypophosphatemia: a search for gender, race, anticipation, or parent of origin effects on disease expression in children. J Clin Endocrinol Metab 81:4075\u20134080. https:\/\/doi.org\/10.1210\/jcem.81.11.8923863","journal-title":"J Clin Endocrinol Metab"},{"key":"1555_CR49","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.bone.2019.01.02","volume":"121","author":"C Zhang","year":"2019","unstructured":"Zhang C, Zhao Z, Sun Y, Xu L, JiaJue R, Cui L, Pang Q, Jiang Y, Li M, Wang O, He X, He S, Nie M, Xing X, Meng X, Zhou X, Yan L, Kaplan JM, Insogna KL, Xia W (2019) Clinical and genetic analysis in a large Chinese cohort of patients with X-linked hypophosphatemia. Bone 121:212\u2013220. https:\/\/doi.org\/10.1016\/j.bone.2019.01.02","journal-title":"Bone"},{"key":"1555_CR50","doi-asserted-by":"publisher","DOI":"10.1093\/jbmrpl\/ziaf018","volume":"9","author":"D Ivanovic-Zuvic","year":"2025","unstructured":"Ivanovic-Zuvic D, Madison A, Jim\u00e9nez M, Oyanadel ML, Gattini N, Guzm\u00e1n C, Cifr\u00e9 M, Silvestre R, Garc\u00eda C, Contreras O, Collins MT, Florenzano P (2025) Factors associated with impaired physical functionality in X-linked hypophosphatemia. JBMR Plus 9:ziaf018. https:\/\/doi.org\/10.1093\/jbmrpl\/ziaf018","journal-title":"JBMR Plus"},{"key":"1555_CR51","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1093\/jbmr\/zjaf063","volume":"40","author":"P Florenzano","year":"2025","unstructured":"Florenzano P, Imel EA, Khan AA, Li Z, Vincent M, Nomura T, Krolczyk S, Johnson B, Ward L (2025) Real-world effectiveness of burosumab vs oral phosphate and active vitamin D in adults with X-linked hypophosphatemia. J Bone Miner Res 40:973\u2013986. https:\/\/doi.org\/10.1093\/jbmr\/zjaf063","journal-title":"J Bone Miner Res"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-026-01555-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-026-01555-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-026-01555-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T09:19:00Z","timestamp":1783675140000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-026-01555-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1555"],"URL":"https:\/\/doi.org\/10.1007\/s00223-026-01555-1","relation":{},"ISSN":["1432-0827"],"issn-type":[{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"20 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"112"}}